Success through careful design and precise executionA high-resolution separation technique developed into a screening platform CEfrag™ offers an innovative, proprietary methodology to identify mM to pM binding interactions between low molecular weight compounds and a therapeutic target, under physiological conditions.

CEfrag™  - The Technology

Fragment Screening by Capillary Electrophoresis

Selcia has established a proprietary approach using capillary electrophoresis (CE) to detect the weak binding interactions between fragments and therapeutic targets. 

Capillary electrophoresis was pioneered as a sensitive and robust screening technique in the 1990's for high throughput screening (HTS). Selcia has acquired the associated IP and adapted it for fragment screening, creating the CEfrag™ Screen.

CE separates neutral and charged molecules by their mobility in a capillary filled with buffer and subjected to a high-voltage field.

The fragment-target interaction is measured through competitive displacement of a probe ligand by a fragment. Detection occurs by UV or LIF.

CEfrag™ is a particularly powerful tool for identifying hits on challenging biological targets, such as protein-protein interactions.

Fragment hits are identified by monitoring a change in the electrophoretic profile of a probe ligand (PL). For high affinity (low off-rate) PLs, a reduction in a PL:target complex is monitored. For weak affinity (high off-rate) PLs, a PL mobility shift is monitored.
 


Probe Ligand

Probe Ligand
Addition of Target Protein

Addition of Target Protein
Effect of Fragments

Effect of Fragments
 

Please contact us for further information. We will be pleased to arrange a teleconference or meeting with our technical experts.